国际英语新闻:New U.S. UN envoy says diplomacy is about "managing points of differentiation"
UNITED NATIONS, Feb. 25 (Xinhua) -- Linda Thomas-Greenfield, the new U.S. ambassador to the United Nations, on Thursday said that diplomacy is about "managing points of differentiation" while making her debut at the world body.
"Throughout my time representing America all over the world, I found that diplomacy is about showing compassion. It's about managing points of differentiation, and it's about bringing people together," Thomas-Greenfield, who was confirmed to be the top U.S. UN envoy by the U.S. Senate on Tuesday, told reporters at the UN headquarters in New York after officially presenting the credentials to UN Secretary-General Antonio Guterres.
The senior U.S. diplomat, who has been serving as a U.S. diplomat for more than 35 years, underscored that the United Nations is the world's "most important forum for bringing people in countries together."
"I take that seriously as a U.S. diplomat," she noted.
Thomas-Greenfield said that "we're clear-eyed about the difficult work that needs to be done from elevating human rights to reforming the UN itself, to addressing conflicts, old and new, around the world."
The new envoy, who was preceded by Kelly Craft, stressed that she was "particularly" looking forward to U.S. presidency of the Security Council in March.
"We're ready to work," she concluded.
相关文章
- 欧美文化:Russian FM visits Algeria to mark 60th anniversary of ties
- 欧美文化:Spanish government sacks spy chief after phone tapping scandal
- 欧美文化:Moroccan, Egyptian FMs discuss prospects of bolstering cooperation
- 欧美文化:Macron visits Berlin on first foreign trip after re-election
- 欧美文化:Ukrainian president, Swedish PM discuss defense support for Ukraine over phone
- 欧美文化:Serbia, China commemorate journalists killed in NATO bombing 23 years ago
- 欧美文化:Two suspects arrested for killing 3 Israelis in stabbing attack
- 欧美文化:Israel celebrates 74th Independence Day
- 欧美文化:Putin, Bennett discuss Ukraine over phone
- 欧美文化:U.S. FDA limits use of Johnson & Johnson COVID-19 vaccine over blood clot risk